Insurancenewsnet.com

RINVOQ® (Upadacitinib) Receives Its Sixth U.S. FDA Approval

https://www.multivu.com/players/English/9092951-abbvie-fda-active-non-radiographic-axial-spondyloarthritis/ Nr-axSpA is a chronic, progressive inflammatory rheumatic ...
GlobalData on MSN

FDA approves AbbVie’s Rinvoq for inflammatory bowel disease

The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...
Seeking Alpha

CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

NORTH CHICAGO, Ill., June 27, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the ...
KTLA

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata

In Study 1, both doses of upadacitinib achieved the primary endpoint, with 45.2% and 55.0% of patients treated with upadacitinib 15 mg and 30 mg, respectively, reaching 80% or more scalp hair coverage ...
Morningstar

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

NORTH CHICAGO, Ill., Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive ...
Hosted on MSN

Ankylosing Spondylitis: How to Deal With Fatigue

Ankylosing spondylitis (AS), a type of arthritis that affects joints, tendons, and ligaments in the lower back and the base of the spine, can make you feel as if your energy has been zapped. It’s a ...